GT Biopharma, Inc. (GTBP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for GT Biopharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.15x | -0.44x | -1.36x | -40.54x | -44.41x | -33.51x |
| P/B Ratio | 0.75x | -3.46x | 1.38x | 72.16x | 117.58x | -32.40x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.50x | 0.72x | 2.12x | 3.35x | 3.14x | 0.16x |
| Quick Ratio | 3.50x | 0.72x | 2.12x | 3.35x | 3.14x | 0.16x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x | -0.90x |
YoY = year-over-year change. Source: FMP..